References
Jan 27, 1975·JAMA : the Journal of the American Medical Association
Nov 8, 1990·The New England Journal of Medicine·G BrownH T Dodge
Dec 19, 1990·JAMA : the Journal of the American Medical Association·J P KaneR J Havel
Nov 1, 1987·Annals of Internal Medicine·M J MalloyP Tun
Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Jan 20, 1984·JAMA : the Journal of the American Medical Association
Jan 1, 1995·European Heart Journal·J Shepherd
Oct 1, 1995·European Heart Journal·W F Armstrong
Jun 9, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·J R Guyton
Sep 18, 2001·Lancet·T J SmildeA F Stalenhoef
Sep 18, 2001·Clinical Therapeutics·H E BaysUNKNOWN Ezetimibe Study Group
Oct 13, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·X Q ZhaoB G Brown
Jan 5, 2002·The New England Journal of Medicine·B G BrownJ J Albers
Oct 2, 2002·Annals of Internal Medicine·Paul S PhillipsUNKNOWN Scripps Mercy Clinical Research Center
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Sep 1, 2004·JAMA : the Journal of the American Medical Association·James A de LemosUNKNOWN Investigators
Jan 20, 2005·Annals of Internal Medicine·Edwin J WhitneyAntonio M Gotto
Mar 10, 2005·The New England Journal of Medicine·John C LaRosaUNKNOWN Treating to New Targets (TNT) Investigators
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Nov 16, 2005·Journal of the American College of Cardiology·Jennifer G RobinsonHelmut Schrott
Nov 17, 2005·JAMA : the Journal of the American Medical Association·Terje R PedersenUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
Apr 12, 2006·Archives of Internal Medicine·J David CurbFrits R Rosendaal
Aug 11, 2006·The New England Journal of Medicine·Pierre AmarencoUNKNOWN Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
Nov 11, 2006·Current Opinion in Lipidology·B Greg BrownXue-Qiao Zhao
Feb 7, 2007·Circulation·Prakash DeedwaniaDan Tzivoni
Mar 27, 2007·JAMA : the Journal of the American Medical Association·John R CrouseUNKNOWN METEOR Study Group
Jul 11, 2007·Current Opinion in Lipidology·John R Guyton
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Nov 7, 2007·The New England Journal of Medicine·John KjekshusUNKNOWN CORONA Group
Apr 1, 2008·The New England Journal of Medicine·John J P KasteleinUNKNOWN ENHANCE Investigators
Apr 10, 2008·JAMA : the Journal of the American Medical Association·Barbara V HowardJianhui Zhu
Apr 19, 2008·Journal of the American College of Cardiology·John R GuytonAndrew M Tershakovec
Apr 29, 2008·European Heart Journal·Magnus SettergrenJohn Pernow
Jun 10, 2008·British Journal of Pharmacology·M J ForrestR F Woltmann
Sep 2, 2008·Lancet·Luigi TavazziUNKNOWN Gissi-HF Investigators
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Dec 17, 2008·Circulation·Ping-Yen LiuJames K Liao
Dec 20, 2008·Journal of the American College of Cardiology·Jerome L FlegWm James Howard
Apr 1, 2009·The New England Journal of Medicine·Bengt C FellströmUNKNOWN AURORA Study Group
Nov 17, 2009·The New England Journal of Medicine·Allen J TaylorMark Turco
Feb 16, 2010·The American Journal of Cardiology·Sergio FazioAndrew M Tershakovec